AU565424B2 - 2,6-dimethyl-4 (nitrophenyl) -1,4-dihydropyridine-3,5 -dicarboxylic acid esters - Google Patents

2,6-dimethyl-4 (nitrophenyl) -1,4-dihydropyridine-3,5 -dicarboxylic acid esters

Info

Publication number
AU565424B2
AU565424B2 AU19941/83A AU1994183A AU565424B2 AU 565424 B2 AU565424 B2 AU 565424B2 AU 19941/83 A AU19941/83 A AU 19941/83A AU 1994183 A AU1994183 A AU 1994183A AU 565424 B2 AU565424 B2 AU 565424B2
Authority
AU
Australia
Prior art keywords
ester
carbon atoms
nitrophenyl
dimethyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19941/83A
Other languages
English (en)
Other versions
AU1994183A (en
Inventor
Katsuo Hatayama
Shoichi Ito
Aturo Nakazato
Toshihisa Ogawa
Jiro Sawada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU1994183A publication Critical patent/AU1994183A/en
Application granted granted Critical
Publication of AU565424B2 publication Critical patent/AU565424B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU19941/83A 1982-04-22 1983-10-06 2,6-dimethyl-4 (nitrophenyl) -1,4-dihydropyridine-3,5 -dicarboxylic acid esters Ceased AU565424B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57067759A JPS58185562A (ja) 1982-04-22 1982-04-22 １，４−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
AU1994183A AU1994183A (en) 1985-04-18
AU565424B2 true AU565424B2 (en) 1987-09-17

Family

ID=13354183

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19941/83A Ceased AU565424B2 (en) 1982-04-22 1983-10-06 2,6-dimethyl-4 (nitrophenyl) -1,4-dihydropyridine-3,5 -dicarboxylic acid esters

Country Status (8)

Country Link
US (1) US4472411A (enExample)
EP (1) EP0092936B1 (enExample)
JP (1) JPS58185562A (enExample)
AU (1) AU565424B2 (enExample)
BE (1) BE898024A (enExample)
DE (1) DE3370620D1 (enExample)
NL (1) NL8303616A (enExample)
SE (1) SE440648B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8314744D0 (en) * 1983-05-27 1983-07-06 Fujisawa Pharmaceutical Co 2 6-disubstituted-1 4-dihydropyridine derivative
EP0127150A3 (en) * 1983-05-27 1987-07-22 Fujisawa Pharmaceutical Co., Ltd. 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
US4730052A (en) * 1984-07-13 1988-03-08 Taisho Pharmaceutical Co., Ltd. Method for preparing unsymmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid diesters
ES8708211A1 (es) * 1985-06-14 1987-10-01 Sankyo Co Un procedimiento para la preparacion de nuevos derivados de 4-(fenil sustituido)-1,4-dihidropiridina.
JPS62174050A (ja) * 1985-10-21 1987-07-30 Nippon Shoji Kk ３−アミノカルボニル−１，４−ジヒドロピリジン−５−カルボン酸誘導体、その製法および医薬組成物
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
JPS62292757A (ja) * 1986-06-12 1987-12-19 Taisho Pharmaceut Co Ltd １，４−ジヒドロピリジン誘導体
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
BE898024A (fr) 1984-04-19
DE3370620D1 (en) 1987-05-07
SE8305467D0 (sv) 1983-10-05
SE8305467L (sv) 1985-04-06
EP0092936B1 (en) 1987-04-01
SE440648B (sv) 1985-08-12
EP0092936A1 (en) 1983-11-02
US4472411A (en) 1984-09-18
AU1994183A (en) 1985-04-18
JPS58185562A (ja) 1983-10-29
JPS635024B2 (enExample) 1988-02-01
NL8303616A (nl) 1985-05-17

Similar Documents

Publication Publication Date Title
DE3378532D1 (en) 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives
AU1994183A (en) 2,6-dimethyl-4 (nitrophenyl) -1,4-dihydropyridine-3,5 -dicarboxylic acid esters
AU557175B2 (en) 2,6-dimethyl-4-(3-nitro phenyl)-1,4-dihydro pyridine-3,5- dicarboxylic acid esters
AU541067B2 (en) 2,6-dimethyl-3,5-dicarboxylates-1,4-dihydropyridines
EP0060897A4 (en) 1,4-DIHYDROPYRIDINE-3,5-DICARBONIC ACID ESTER DERIVATIVES.
AU2227483A (en) Pharmaceutical dihydropyridines
AU566346B2 (en) Dihydro-pyridyl cyclic imidate esters
AU554571B2 (en) Heterocyclic substituted dihydropyridine cardiovascular agents
GB8415523D0 (en) 1,4-dihydro-pyridine-3,5-dicarboxylic acid diester derivatives
EP0168789A3 (en) Method for preparing unsymmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid diesters
GB2122192B (en) Dihydropyridines
DE3378533D1 (en) 1,4-dihydropyridine derivatives
GB2120251B (en) Dihydropyridines
AU1169583A (en) 1,4,dihydropyridine-3,5-dicarboxylic acid esters
DE3378313D1 (en) 1,4-dihydropyridine derivatives
AU557521B2 (en) 3-(2-fruoyl)-5-alkoxy-2,6-dimethyl-4-(2-nitrophenyl)- 1,4-dihydropyridine
GB2120668B (en) Dihydropyridines
DE3478685D1 (en) 1,4-dihydropyridine compound
GB8405504D0 (en) Stripping stacks
ZM5884A1 (en) Herbicidal 2,6-bis-fluoromethyl-dihydropyridine-3,5-dicarboxylic acid esters
AU1395183A (en) 7beta-acylamido-3-cephem-4-carboxylic acid compounds
DE3171237D1 (en) 1,4-dihydropyridine-3,5-dicarboxylic ester derivatives
AU1167583A (en) Battery jump leads
JPS5753479A (en) Substituted 2,5,7-trioxane-bicyclo(2,2,2)octane- 6-one, 3,6,8-trioxa-bicyclo(3,2,1)octane-4-one, 1,3-dioxane-2-carboxylic acid compound and 1,3-dioxolane-2-carboxylic acid compound and manufacture thereof
IE842078L (en) Herbicidal 2,6-bis-fluoromethyl-dihydropyridine-¹3,5-dicarboxylic acid esters¹6-bis-fluoromethyl-dihydropyridine-3,5-dicarboxylic acid¹esters